NCT06854952 - A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions

Overweight or Obesity

Interventions

DRUG

TERN-601

Investigational drug

OTHER

Matching Placebo

Matching placebo

Trial Locations (17)

22206

FALCON Research Site, Arlington

32127

FALCON Research Site, Port Orange

35209

FALCON Research Site, Homewood

35294

FALCON Research Site, Birmingham

40213

FALCON Research Site, Louisville

44122

FALCON Research Site, Beachwood

55905

FALCON Research Site, Rochester

63303

FALCON Research Site, City of Saint Peters

70072

FALCON Research Site, Marrero

75230

FALCON Research Site, Dallas

77079

FALCON Research Site, Houston

78229

FALCON Research Site, San Antonio

84790

FALCON Research Site, St. George

85712

FALCON Research Site, Tucson

91978

FALCON Research Site, Spring Valley

97504

FALCON Research Site, Medford

02114

FALCON Research Site, Boston

All Listed Sponsors

lead

Terns, Inc.

INDUSTRY